Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2020

01-12-2020 | Giant Cell Arteritis | Research

Reuma.pt/vasculitis – the Portuguese vasculitis registry

Authors: Cristina Ponte, Nikita Khmelinskii, Vítor Teixeira, Karine Luz, Daniela Peixoto, Marília Rodrigues, Mariana Luís, Lídia Teixeira, Sandra Sousa, Nathalie Madeira, Joana A. Aleixo, Teresa Pedrosa, Sofia Serra, Raquel Campanilho-Marques, Walter Castelão, Ana Cordeiro, Inês Cordeiro, Sílvia Fernandes, Carla Macieira, Pedro Madureira, Armando Malcata, Romana Vieira, Fernando Martins, Graça Sequeira, Jaime C. Branco, Lúcia Costa, José Vaz Patto, José Canas da Silva, José A. Pereira da Silva, Carmo Afonso, Helena Canhão, Maria J. Santos, Raashid A. Luqmani, João E. Fonseca

Published in: Orphanet Journal of Rare Diseases | Issue 1/2020

Login to get access

Abstract

Background

The vasculitides are a group of rare diseases with different manifestations and outcomes. New therapeutic options have led to the need for long-term registries. The Rheumatic Diseases Portuguese Register, Reuma.pt, is a web-based electronic clinical record, created in 2008, which currently includes specific modules for 12 diseases and > 20,000 patients registered from 79 rheumatology centres. On October 2014, a dedicated module for vasculitis was created as part of the European Vasculitis Society collaborative network, enabling prospective collection and central storage of encrypted data from patients with this condition. All Portuguese rheumatology centres were invited to participate. Data regarding demographics, diagnosis, classification criteria, assessment tools, and treatment were collected. We aim to describe the structure of Reuma.pt/vasculitis and characterize the patients registered since its development.

Results

A total of 687 patients, with 1945 visits, from 13 centres were registered; mean age was 53.4 ± 19.3 years at last visit and 68.7% were females. The most common diagnoses were Behçet’s disease (BD) (42.5%) and giant cell arteritis (GCA) (17.8%). Patients with BD met the International Study Group criteria and the International Criteria for BD in 85.3 and 97.2% of cases, respectively. Within the most common small- and medium-vessel vasculitides registered, median [interquartile range] Birmingham Vasculitis Activity Score (BVAS) at first visit was highest in patients with ANCA-associated vasculitis (AAV) (17.0 [12.0]); there were no differences in the proportion of patients with AAV or polyarteritis nodosa who relapsed (BVAS≥1) or had a major relapse (≥1 major BVAS item) during prospective assessment (p = 1.00, p = 0.479). Biologic treatment was prescribed in 0.8% of patients with GCA, 26.7% of patients with AAV, and 7.6% of patients with BD. There were 34 (4.9%) deaths reported.

Conclusions

Reuma.pt/vasculitis is a bespoke web-based registry adapted for routine care of patients with this form of rare and complex diseases, allowing an efficient data-repository at a national level with the potential to link with other international databases. It facilitates research, trials recruitment, service planning and benchmarking.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Ponte C, Sznajd J, O'Neill L, Luqmani RA. Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases. Clin Exp Rheumatol. 2014;32:S118–25. Ponte C, Sznajd J, O'Neill L, Luqmani RA. Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases. Clin Exp Rheumatol. 2014;32:S118–25.
3.
go back to reference Canhão H, Faustino A, Martins F, Fonseca JE. Rheumatic diseases Portuguese register board coordination, Portuguese Society of Rheumatology. Reuma.Pt - the rheumatic diseases Portuguese register. Acta Reumatol Port. 2011;36:45–56.PubMed Canhão H, Faustino A, Martins F, Fonseca JE. Rheumatic diseases Portuguese register board coordination, Portuguese Society of Rheumatology. Reuma.Pt - the rheumatic diseases Portuguese register. Acta Reumatol Port. 2011;36:45–56.PubMed
4.
go back to reference Santos MJ, Canhão H, Mourão AF, Oliveira Ramos F, Ponte C, Duarte C, et al. Reuma.Pt contribution to the knowledge of immune-mediated systemic rheumatic diseases. Acta Reumatol Port. 2017;42:232–9.PubMed Santos MJ, Canhão H, Mourão AF, Oliveira Ramos F, Ponte C, Duarte C, et al. Reuma.Pt contribution to the knowledge of immune-mediated systemic rheumatic diseases. Acta Reumatol Port. 2017;42:232–9.PubMed
5.
go back to reference Santos MJ, Canas da Silva J. Reuma.Pt - structure and innovation. Acta Reumatol Port. 2018;43:8–9.PubMed Santos MJ, Canas da Silva J. Reuma.Pt - structure and innovation. Acta Reumatol Port. 2018;43:8–9.PubMed
6.
go back to reference Luqmani RA, Craven A, Sznajd J, Basu N, Barrett J, Jayne D, et al. The UK & Ireland Vasculitis Registry (UKIVAS): cross-sectional data on the first 2290 patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV). Rheumatology. 2017;56:iii20–2.CrossRef Luqmani RA, Craven A, Sznajd J, Basu N, Barrett J, Jayne D, et al. The UK & Ireland Vasculitis Registry (UKIVAS): cross-sectional data on the first 2290 patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV). Rheumatology. 2017;56:iii20–2.CrossRef
7.
go back to reference Padjas A, Sznajd J, Szczeklik W, Wójcik K, Wawrzycka K, Musiał J. Rare disease registries: an initiative to establish vasculitis registry in Poland. Pol Arch Med Wewn. 2014;124:143–4.PubMed Padjas A, Sznajd J, Szczeklik W, Wójcik K, Wawrzycka K, Musiał J. Rare disease registries: an initiative to establish vasculitis registry in Poland. Pol Arch Med Wewn. 2014;124:143–4.PubMed
9.
go back to reference Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.PubMedCrossRef Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.PubMedCrossRef
10.
go back to reference Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.PubMedCrossRef Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.PubMedCrossRef
11.
go back to reference Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.PubMedCrossRef Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.PubMedCrossRef
12.
go back to reference Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088–93.PubMedCrossRef Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088–93.PubMedCrossRef
13.
go back to reference Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101–7.PubMedCrossRef Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101–7.PubMedCrossRef
14.
go back to reference Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094–100.PubMedCrossRef Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094–100.PubMedCrossRef
15.
go back to reference Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 1990;33:1114–21.PubMedCrossRef Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 1990;33:1114–21.PubMedCrossRef
16.
go back to reference Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63:65–81.CrossRef Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63:65–81.CrossRef
17.
go back to reference Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation. 2004;110:2747–71.PubMedCrossRef Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation. 2004;110:2747–71.PubMedCrossRef
18.
go back to reference International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335:1078–80. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335:1078–80.
19.
go back to reference International Team for the Revision of the International Criteria for Behcet’s Disease. Revision of the international criteria for Behcet’s disease (ICBD). Clin Exp Rheumatol. 2006;24:S14–5. International Team for the Revision of the International Criteria for Behcet’s Disease. Revision of the international criteria for Behcet’s disease (ICBD). Clin Exp Rheumatol. 2006;24:S14–5.
20.
go back to reference International Team for the Revision of the International Criteria for Behcet’s Disease. The international criteria for Behçet's disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338–47.CrossRef International Team for the Revision of the International Criteria for Behcet’s Disease. The international criteria for Behçet's disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338–47.CrossRef
21.
go back to reference De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis. 2011;70:1183–90.PubMedCrossRef De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis. 2011;70:1183–90.PubMedCrossRef
22.
go back to reference Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, et al. ACR/EULAR-endorsed study to develop diagnostic and classification criteria for Vasculitis (DCVAS). Clin Exp Nephrol. 2013;17:619–21.PubMedCrossRef Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, et al. ACR/EULAR-endorsed study to develop diagnostic and classification criteria for Vasculitis (DCVAS). Clin Exp Nephrol. 2013;17:619–21.PubMedCrossRef
23.
go back to reference Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 1996;75:17–28.CrossRef Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 1996;75:17–28.CrossRef
24.
go back to reference Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, et al. The five factor score revisited: assessment of prog- noses of systemic necrotizing vasculitides based on the French Vasculitis study group (FVSG) cohort. Medicine (Baltimore). 2011;90:19–27.CrossRef Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, et al. The five factor score revisited: assessment of prog- noses of systemic necrotizing vasculitides based on the French Vasculitis study group (FVSG) cohort. Medicine (Baltimore). 2011;90:19–27.CrossRef
25.
go back to reference Suppiah R, Judge A, Batra R, Flossmann O, Harper L, Höglund P, et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken). 2011;63:588–96.CrossRef Suppiah R, Judge A, Batra R, Flossmann O, Harper L, Höglund P, et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken). 2011;63:588–96.CrossRef
26.
go back to reference Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis activity score (version3). Ann Rheum Dis. 2009;68:1827–32.PubMedCrossRef Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis activity score (version3). Ann Rheum Dis. 2009;68:1827–32.PubMedCrossRef
27.
go back to reference Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage COS. Development and initial validation of the Vasculitis damage index (VDI) for the standardised clinical assessment of damage in the systemic Vasculitides. Arthritis Rheum. 1997;40:371–80.PubMedCrossRef Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage COS. Development and initial validation of the Vasculitis damage index (VDI) for the standardised clinical assessment of damage in the systemic Vasculitides. Arthritis Rheum. 1997;40:371–80.PubMedCrossRef
28.
go back to reference Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69:798–806.PubMedCrossRef Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69:798–806.PubMedCrossRef
29.
go back to reference Dolezalova P, Price-Kuehne FE, Özen S, Benseler SM, Cabral DA, Anton J, et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis activity score (PVAS). Ann Rheum Dis. 2013;72:1628–33.PubMedCrossRef Dolezalova P, Price-Kuehne FE, Özen S, Benseler SM, Cabral DA, Anton J, et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis activity score (PVAS). Ann Rheum Dis. 2013;72:1628–33.PubMedCrossRef
30.
go back to reference Dolezalova P, Wilkinson N, Brogan PA, Antón J, Benseler S, Brunner J, et al. Paediatric Vasculitis damage index: a new tool for standardised disease assessment. Ann Rheum Dis. 2014;73(Suppl2):696–7. Dolezalova P, Wilkinson N, Brogan PA, Antón J, Benseler S, Brunner J, et al. Paediatric Vasculitis damage index: a new tool for standardised disease assessment. Ann Rheum Dis. 2014;73(Suppl2):696–7.
31.
go back to reference Ntatsaki E, Carruthers D, Chakravarty K, D'Cruz D, Harper L, Jayne D, et al. BSR and BHPR standards, guidelines and audit working group. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014;53:2306–9.CrossRef Ntatsaki E, Carruthers D, Chakravarty K, D'Cruz D, Harper L, Jayne D, et al. BSR and BHPR standards, guidelines and audit working group. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014;53:2306–9.CrossRef
32.
go back to reference Khmelinskii N, Seixas I, Ponte C, Fonseca JE, Macieira C. The added value of a Vasculitis Clinic in a tertiary referral hospital. Acta Medica Port. 2018;31:614–7.CrossRef Khmelinskii N, Seixas I, Ponte C, Fonseca JE, Macieira C. The added value of a Vasculitis Clinic in a tertiary referral hospital. Acta Medica Port. 2018;31:614–7.CrossRef
33.
go back to reference Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70:488–94.PubMedCrossRef Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70:488–94.PubMedCrossRef
34.
go back to reference Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Höglund P, et al. Damage in the ANCA-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Ann Rheum Dis. 2015;74:177–84.PubMedCrossRef Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Höglund P, et al. Damage in the ANCA-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Ann Rheum Dis. 2015;74:177–84.PubMedCrossRef
35.
go back to reference Merkel PA, Aydin SZ, Boers M, Direskeneli H, Herlyn K, Seo P, et al. The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J Rheumatol. 2011;38:1480–6.PubMedPubMedCentralCrossRef Merkel PA, Aydin SZ, Boers M, Direskeneli H, Herlyn K, Seo P, et al. The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J Rheumatol. 2011;38:1480–6.PubMedPubMedCentralCrossRef
36.
go back to reference Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377:317e28. Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377:317e28.
37.
go back to reference Sznajd J, Salama AD, Jayne D, Chaudhry A, Robson M, Rosa J, et al. United Kingdom & Ireland vasculitis registry (UKIVAS): cross- sectional data on the first 1085 patients. Arthritis Rheumatol. 2014;66(suppl10):773. Sznajd J, Salama AD, Jayne D, Chaudhry A, Robson M, Rosa J, et al. United Kingdom & Ireland vasculitis registry (UKIVAS): cross- sectional data on the first 1085 patients. Arthritis Rheumatol. 2014;66(suppl10):773.
38.
go back to reference Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, Höglund P, et al. French Vasculitis study group (FVSG) and the European Vasculitis Society (EUVAS). Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis. 2013;72:1003–10.PubMedCrossRef Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, Höglund P, et al. French Vasculitis study group (FVSG) and the European Vasculitis Society (EUVAS). Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis. 2013;72:1003–10.PubMedCrossRef
39.
go back to reference Solans-Laqué R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo MJ, Martínez-Valle F, et al. Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine (Baltimore). 2017;96:e6083. https://doi.org/10.1097/MD.0000000000006083.CrossRef Solans-Laqué R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo MJ, Martínez-Valle F, et al. Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine (Baltimore). 2017;96:e6083. https://​doi.​org/​10.​1097/​MD.​0000000000006083​.CrossRef
40.
42.
go back to reference Hruskova Z, Jancova E, Lanska V, Svojanovsky J, Klaboch J, Nemec P, et al. Characteristics and outcomes of patients with ANCA-associated vasculitis in the Czech population. Presse Med. 2013;42(suppl):664–5.CrossRef Hruskova Z, Jancova E, Lanska V, Svojanovsky J, Klaboch J, Nemec P, et al. Characteristics and outcomes of patients with ANCA-associated vasculitis in the Czech population. Presse Med. 2013;42(suppl):664–5.CrossRef
43.
go back to reference Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG. Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study. Clin Rheumatol. 2018;37:737–47.PubMedCrossRef Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG. Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study. Clin Rheumatol. 2018;37:737–47.PubMedCrossRef
45.
go back to reference de Souza-Ramalho P, D'Almeida MF, Freitas JP, Pinto J. Behçet's disease in Portugal. Acta Medica Port. 1991;4:79–82. de Souza-Ramalho P, D'Almeida MF, Freitas JP, Pinto J. Behçet's disease in Portugal. Acta Medica Port. 1991;4:79–82.
46.
go back to reference Grupo Nacional para o Estudo da Doença de Behçet, Jorge Crespo. Behçet’s disease - a national casuistic. Med Int. 1997;4:225–32. Grupo Nacional para o Estudo da Doença de Behçet, Jorge Crespo. Behçet’s disease - a national casuistic. Med Int. 1997;4:225–32.
47.
go back to reference Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636–43.PubMedCrossRef Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636–43.PubMedCrossRef
48.
go back to reference Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583–94.PubMedCrossRef Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583–94.PubMedCrossRef
49.
go back to reference Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68:318–23.PubMedCrossRef Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68:318–23.PubMedCrossRef
50.
go back to reference Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR expert committee. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis. 2008;67:1656–62.PubMedCrossRef Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR expert committee. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis. 2008;67:1656–62.PubMedCrossRef
51.
go back to reference Robson JC, Dawson J, Doll H, Cronholm PF, Milman N, Kellom K, et al. Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire. Ann Rheum Dis. 2018;77:1157–64.PubMed Robson JC, Dawson J, Doll H, Cronholm PF, Milman N, Kellom K, et al. Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire. Ann Rheum Dis. 2018;77:1157–64.PubMed
Metadata
Title
Reuma.pt/vasculitis – the Portuguese vasculitis registry
Authors
Cristina Ponte
Nikita Khmelinskii
Vítor Teixeira
Karine Luz
Daniela Peixoto
Marília Rodrigues
Mariana Luís
Lídia Teixeira
Sandra Sousa
Nathalie Madeira
Joana A. Aleixo
Teresa Pedrosa
Sofia Serra
Raquel Campanilho-Marques
Walter Castelão
Ana Cordeiro
Inês Cordeiro
Sílvia Fernandes
Carla Macieira
Pedro Madureira
Armando Malcata
Romana Vieira
Fernando Martins
Graça Sequeira
Jaime C. Branco
Lúcia Costa
José Vaz Patto
José Canas da Silva
José A. Pereira da Silva
Carmo Afonso
Helena Canhão
Maria J. Santos
Raashid A. Luqmani
João E. Fonseca
Publication date
01-12-2020

Other articles of this Issue 1/2020

Orphanet Journal of Rare Diseases 1/2020 Go to the issue